Region-specific proteolysis differentially regulates type 1 inositol 1,4,5-trisphosphate receptor activity.

J Biol Chem

Department of Pharmacology and Physiology, University of Rochester, Rochester, New York 14642. Electronic address:

Published: July 2017

The inositol 1,4,5 trisphosphate receptor (IPR) is an intracellular Ca release channel expressed predominately on the membranes of the endoplasmic reticulum. IPR1 can be cleaved by caspase or calpain into at least two receptor fragments. However, the functional consequences of receptor fragmentation are poorly understood. Our previous work has demonstrated that IPR1 channels, formed following either enzymatic fragmentation or expression of the corresponding complementary polypeptide chains, retain tetrameric architecture and are still activated by IP binding despite the loss of peptide continuity. In this study, we demonstrate that region-specific receptor fragmentation modifies channel regulation. Specifically, the agonist-evoked temporal Ca release profile and protein kinase A modulation of Ca release are markedly altered. Moreover, we also demonstrate that activation of fragmented IPR1 can result in a distinct functional outcome. Our work suggests that proteolysis of IPR1 may represent a novel form of modulation of IPR1 channel function and increases the repertoire of Ca signals achievable through this channel.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512067PMC
http://dx.doi.org/10.1074/jbc.M117.789917DOI Listing

Publication Analysis

Top Keywords

receptor fragmentation
8
receptor
5
ipr1
5
region-specific proteolysis
4
proteolysis differentially
4
differentially regulates
4
regulates type
4
type inositol
4
inositol 145-trisphosphate
4
145-trisphosphate receptor
4

Similar Publications

The complement system and neutrophils constitute the two main pillars of the host innate immune defense against infection by bacterial pathogens. Here, we identify T-Mac, a novel virulence factor of the periodontal pathogen Treponema denticola that allows bacteria to evade both defense systems. We show that T-Mac is expressed as a pre-protein that is cleaved into two functional units.

View Article and Find Full Text PDF

Background: Fluorescence molecular imaging, a potent and non-invasive technique, has become indispensable in medicine for visualizing molecular processes. In surgical oncology, it aids treatment by allowing visualization of tumor cells during fluorescence-guided surgery (FGS). Targeting the urokinase plasminogen activator receptor (uPAR), overexpressed during tissue remodeling and inflammation, holds promise for advancing FGS by specifically highlighting tumors.

View Article and Find Full Text PDF

Research Question: Are the combined genotypes and haplotypes of vitamin D receptor (VDR) gene polymorphisms (FokI, ApaI and TaqI) associated with susceptibility to polycystic ovary syndrome (PCOS) and metabolic features of the disease?

Design: This case-control study included 46 women with PCOS and 48 controls. Genotypes of the VDR gene were determined using the polymerase chain reaction-restriction fragment length polymorphism method. Waist circumference, and parameters of lipid and glucose metabolism were evaluated in all women.

View Article and Find Full Text PDF

SARS-CoV-2 has continued spreading around the world in recent years since the initial outbreak in 2019, frequently developing into new variants with greater human infectious capacity. SARS-CoV-2 and its mutants use the angiotensin-converting enzyme 2 (ACE2) as a cellular entry receptor, which has triggered several therapeutic strategies against COVID-19 relying on the use of ACE2 recombinant proteins as decoy receptors. In this work, we propose an ACE2 silent Fc fusion protein (ACE2-hFcLALA) as a candidate therapy against COVID-19.

View Article and Find Full Text PDF

Breast cancer is the most frequent non-dermatologic malignancy in women. Breast cancer is characterized by the expression of the human epidermal growth factor receptor type 2 (HER2), and the presence or lack of estrogen receptor (ER) and progesterone receptor (PR) expression. HER2 overexpression is reported in about 20 to 25% of breast cancer patients, which is usually linked to cancer progression, metastases, and poor survival.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!